SU

Sunwin Stevia International IncOOTC SUWN Stock Report

Last reporting period 31 Oct, 2022

Updated —

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

SUWN Stock Analysis

SU

Uncovered

Sunwin Stevia International Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-9/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

199.63 B

Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.

View Section: Eyestock Rating